Please login to the form below
UK government
This page shows the latest UK government news and features for those working in and with pharma, biotech and healthcare.
Sanofi, GSK to launch human trials of COVID-19 vaccine
In July, the UK government agreed a deal with the drugmakers for 60 million doses of the protein-based vaccine. ... A week later, Sanofi and GSK forged another agreement with the US government for 100 million doses of their vaccine.
Latest news
-
Valneva announces major COVID-19 vaccine partnership with UK government
The agreement allows for 60 million doses to be supplied by Valneva to the UK government in the second half of next year, if vaccine development is successful. ... Thomas Lingelbach, CEO of Valneva, commented: “We are honoured to have been chosen by
-
Trials resume for AZ/Oxford University COVID-19 vaccine
The pause was instituted after a patient in the UK suffered a reported side effect. ... The phase 3 trials involve some 30, 000 participants in the US, as well as participants in the UK, Brazil and South Africa.
-
First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
by UK-based SpyBiotech and the Serum Institute of India. ... This year, the company raised £10m in funding from Oxford Sciences Innovation, the capital investor for Oxford University, and the UK government’s Future Fund.
-
COVID-19 vaccine ‘unlikely’ to be available this year, says UK’s chief medical officer
The UK’s chief medical officer Chris Whitty has said it is unlikely that there will be a vaccine for COVID-19 before winter 2021. ... The UK government has said that schools in England are expected to return on a full-time basis, and will open for all
-
Public Health England to be axed over coronavirus response
In March, the government paused community coronavirus testing and tracing, a move that has since been widely criticised by health experts and scientific advisers. ... Public health experts and senior doctors in the UK have defended PHE and accused
More from news
Approximately 9 fully matching, plus 399 partially matching documents found.
Latest Intelligence
-
Why pharma must trust the science of behaviour
The rationale? That behavioural scientists’ influence over the UK government’s COVID response caused a delay in lockdown that cost thousands of lives. ... Similarly, the UK government’s Behavioural Insight Team claims good successes in education,
-
Things are going to be different
But the significantly lower rates in France, Germany and the UK show that this is not universally true and remind us that country-by-country variations will be significant. ... homes. Indeed, in the UK it is government that has approached the industry
-
Behaviour change during the coronavirus pandemic
In the UK, the government relied on its preferred nudge theory to kick-start behaviour change, rather than implementing more draconian measures straight away.
-
The global antibiotic crisis: a 2020 perspective
The project is part of the UK government’s five-year, multi-agency action plan that includes improved stewardship to minimise the chances of resistant strains emerging. ... UK Government is serious about fixing the broken market for the long term.
-
Tackling antimicrobial resistance on multiple fronts
From a UK perspective, the challenge of getting the right antibiotic the first time around is exemplified in the current treatment of urinary tract infections (UTIs). ... We argue that ‘delinking’ strategies like those being trialled by the UK
More from intelligence
Approximately 0 fully matching, plus 54 partially matching documents found.
Latest appointments
-
Pfizer’s Alan Maine moves to Edelman
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... Prior to his time with Pfizer, Maine was
-
Medicines Discovery Catapult appoints CEO
As chief executive, he will primarily work with the board of directors and government organisation Innovate UK to develop and implement a new five-year business plan for the drug discovery ... The Catapult will engage the UK's experienced drug discovery
-
Innovate UK appoints director for health and life sciences
In his new position, Campbell will drive the development and delivery of the UK government-sponsored agency's life sciences and health sector. ... Dr Ruth McKernan, chief executive of Innovate UK, said: “Ian Campbell will make a strong addition to the
-
Dr Keith Bragman joins Alacrita
Gates Foundation and at the UK government's department for international development.
-
firstlight appoints Burson-Marsteller's Christian Petrovic
Prior to this, Price served as communications and public affairs lead at e-skills UK, working with clients and government policy makers to inform business objectives and strategy.
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Modernising the Mental Health Act: Published Today
The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018. The final report of the independent review of the Mental Health Act 1983 ‘Modernising the Mental Health Act’ has been published.
-
Tackling obesity via green prescribing: A piece of cake or a half-baked strategy?
In the past month the Government has announced two vital new policies aimed at improving the physical health of people in the UK using preventative strategies. ... If the UK Government is to make a success out of green prescribing and the Obesity Strategy
-
From nature to art galleries: thinking differently about healthcare
Yet it’s also a time when 1 in 3 patients lack clear information about their condition (2) and physical inactivity is responsible for one in six UK deaths (3). Opportunity
-
Are supermarkets responsible for public health?
PLoS One 2017; 12(5). [Accessed December 18, 2019. 2. https://www.gov.uk/government/publications/health-matters-obesity-and-the-food-environment/health-matters-obesity-and-the-food-environment--2. ... 3.
-
Antibiotic resistance: The silent pandemic
Available at: https://www.yourgenome.org/facts/what-is-antibiotic-resistance. Accessed November 2019. HM Government. Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan. ... Available at:
More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Roche’s Ocrevus boasts positive long-term data in MS
- Leadership change within Bedrock Group
- Lilly starts large-scale trial of tirzepatide in diabetic heart disease
- Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
- AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
